DNA Repair Gene (XPD, XRCC4, and XRCC1) Polymorphisms in Patients with Endometrial Hyperplasia: A Pilot Study

Overview

Journal Med Sci Monit Basic Res

Specialty Biotechnology

Date 2018 Oct 3

PMID 30275440

Authors

Ebru Ozturk

Sacide Pehlivan

Ozcan Balat

Mete Gurol Ugur

Huseyin Caglayan Ozcan

Suna Erkilic

Affiliations

Soon will be listed here.

Abstract

BACKGROUND In this study, we aimed to evaluate the association between endometrial hyperplasia and DNA repair gene (XPD, XRCC4, and XRCC1) polymorphisms. MATERIAL AND METHODS There were 114 cases enrolled in the study in 4 groups: simple endometrial hyperplasia (SH) (Group 1), complex endometrial hyperplasia without atypia (CH) (Group 2), complex atypical endometrial hyperplasia (CAH) (Group 3), and normal endometrium (NE) (Group 4). Of these cases, 37 cases had SH, 36 cases had CH, 16 cases had CAH, and 25 cases had NE. To evaluate an association between atypia and DNA repair genes, we consider a group that included both SH and CH, the endometrial hyperplasia without atypia cases (Group 5). Genomic DNA was isolated from paraffin-embedded endometrial tissue collected from the Pathology Department of Gaziantep University Medical School. Polymerase chain reaction (PCR) and/or restriction fragment length polymorphism (RFLP) method was used for evaluating of XPD (-751), XRCC4 (-1394 and a variable number of tandem repeats in intron 3), and XRCC1 (-399) genes. RESULTS We observed a notable distinction in patients having endometrial hyperplasia without atypia (the SH+CH group) and the CAH group in terms of XPD (-751) gene polymorphisms. A notable contrast was observed in patients with endometrial hyperplasia without atypia (the SH+CH group) and the NE group in terms of XRCC4 (VNTR intron 3) polymorphisms (P=0.026, P=0.018, respectively). CONCLUSIONS It was evident the DNA repair gene XPD and XRCC4 polymorphisms had a role in the pathophysiology of endometrial hyperplasia.

References

Unal M, Guven M, Batar B, Ozaydin A, Sarici A, Devranoglu K . Polymorphisms of DNA repair genes XPD and XRCC1 and risk of cataract development. Exp Eye Res. 2007; 85(3):328-34. DOI: 10.1016/j.exer.2007.06.003. View

Nieminen T, Gylling A, Abdel-Rahman W, Nuorva K, Aarnio M, Renkonen-Sinisalo L . Molecular analysis of endometrial tumorigenesis: importance of complex hyperplasia regardless of atypia. Clin Cancer Res. 2009; 15(18):5772-83. DOI: 10.1158/1078-0432.CCR-09-0506. View

Hansen R, Sorensen M, Tjonneland A, Overvad K, Wallin H, Raaschou-Nielsen O . XPA A23G, XPC Lys939Gln, XPD Lys751Gln and XPD Asp312Asn polymorphisms, interactions with smoking, alcohol and dietary factors, and risk of colorectal cancer. Mutat Res. 2007; 619(1-2):68-80. DOI: 10.1016/j.mrfmmm.2007.02.002. View

Ellenson L . The molecular biology of endometrial tumorigenesis: does it have a message?. Int J Gynecol Pathol. 2000; 19(4):310-3. DOI: 10.1097/00004347-200010000-00003. View

Doherty J, Weiss N, Fish S, Fan W, Loomis M, Sakoda L . Polymorphisms in nucleotide excision repair genes and endometrial cancer risk. Cancer Epidemiol Biomarkers Prev. 2011; 20(9):1873-82. PMC: 3169742. DOI: 10.1158/1055-9965.EPI-11-0119. View

Jiang J, Zhang X, Yang H, Wang W . Polymorphisms of DNA repair genes: ADPRT, XRCC1, and XPD and cancer risk in genetic epidemiology. Methods Mol Biol. 2008; 471:305-33. DOI: 10.1007/978-1-59745-416-2_16. View

De Ruyck K, Wilding C, van Eijkeren M, Morthier R, Tawn E, Thierens H . Microsatellite polymorphisms in DNA repair genes XRCC1, XRCC3 and XRCC5 in patients with gynecological tumors: association with late clinical radiosensitivity and cancer incidence. Radiat Res. 2005; 164(3):237-44. DOI: 10.1667/rr3417.1. View

Taylor R, Thistlethwaite A, Caldecott K . Central role for the XRCC1 BRCT I domain in mammalian DNA single-strand break repair. Mol Cell Biol. 2002; 22(8):2556-63. PMC: 133733. DOI: 10.1128/MCB.22.8.2556-2563.2002. View

Morice P, Leary A, Creutzberg C, Abu-Rustum N, Darai E . Endometrial cancer. Lancet. 2015; 387(10023):1094-1108. DOI: 10.1016/S0140-6736(15)00130-0. View

10.

Erdem O, Erdem M, Erdem A, Memis L, Akyol G . Expression of vascular endothelial growth factor and assessment of microvascular density with CD 34 and endoglin in proliferative endometrium, endometrial hyperplasia, and endometrial carcinoma. Int J Gynecol Cancer. 2007; 17(6):1327-32. DOI: 10.1111/j.1525-1438.2007.00942.x. View

11.

Cifci S, Yilmaz M, Pehlivan M, Sever T, Okan V, Pehlivan S . DNA repair genes polymorphisms in multiple myeloma: no association with XRCC1 (Arg399Gln) polymorphism, but the XRCC4 (VNTR in intron 3 and G-1394T) and XPD (Lys751Gln) polymorphisms is associated with the disease in Turkish patients. Hematology. 2011; 16(6):361-7. DOI: 10.1179/102453311X13127324303399. View

12.

Romanowicz-Makowska H, Smolarz B, Houli A, Szyllo K . Single nucleotide polymorphism in DNA base excision repair genes XRCC1 and hOGG1 and the risk of endometrial carcinoma in the Polish population. Pol J Pathol. 2011; 62(2):89-94. View

13.

Feng Y, Shiozawa T, Miyamoto T, Kashima H, Kurai M, Suzuki A . BRAF mutation in endometrial carcinoma and hyperplasia: correlation with KRAS and p53 mutations and mismatch repair protein expression. Clin Cancer Res. 2005; 11(17):6133-8. DOI: 10.1158/1078-0432.CCR-04-2670. View

14.

El-Khamisy S, Masutani M, Suzuki H, Caldecott K . A requirement for PARP-1 for the assembly or stability of XRCC1 nuclear foci at sites of oxidative DNA damage. Nucleic Acids Res. 2003; 31(19):5526-33. PMC: 206461. DOI: 10.1093/nar/gkg761. View

15.

Wang L, Ma J, Yang B, Jing F, Hu Y . XRCC2 Polymorphisms and Environmental Factors Predict High Risk of Colorectal Cancer. Med Sci Monit. 2018; 24:2858-2863. PMC: 5961417. DOI: 10.12659/MSM.904935. View

16.

Baak J, Path F, Hermsen M, Meijer G, Schmidt J, Janssen E . Genomics and proteomics in cancer. Eur J Cancer. 2003; 39(9):1199-215. DOI: 10.1016/s0959-8049(03)00265-x. View

17.

Ozler A, Kuscu N, Temiz P, Kandiloglu A, Koyuncu F . Leptin expression in proliferative, secretory and hyperplastic endometrial tissues. J Turk Ger Gynecol Assoc. 2014; 12(3):157-61. PMC: 3939273. DOI: 10.5152/jtgga.2011.37. View

18.

Jelonek K, Gdowicz-Klosok A, Pietrowska M, Borkowska M, Korfanty J, Rzeszowska-Wolny J . Association between single-nucleotide polymorphisms of selected genes involved in the response to DNA damage and risk of colon, head and neck, and breast cancers in a Polish population. J Appl Genet. 2010; 51(3):343-52. DOI: 10.1007/BF03208865. View

19.

Weiss J, Weiss N, Ulrich C, Doherty J, Chen C . Nucleotide excision repair genotype and the incidence of endometrial cancer: effect of other risk factors on the association. Gynecol Oncol. 2006; 103(3):891-6. DOI: 10.1016/j.ygyno.2006.05.020. View

20.

Wu P, Frit P, Meesala S, Dauvillier S, Modesti M, Andres S . Structural and functional interaction between the human DNA repair proteins DNA ligase IV and XRCC4. Mol Cell Biol. 2009; 29(11):3163-72. PMC: 2682001. DOI: 10.1128/MCB.01895-08. View